Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Sources of Innovation for Drugs of the Future

Posted on June 6th, 2016 by

Pharma R&D

rowers

Innovative drug targets are necessary if precision medicine is to become the norm. Collaboration will be the enabler in developing novel drug therapies: Continue reading “Sources of Innovation for Drugs of the Future” »

Building models for rare diseases

Posted on June 2nd, 2016 by

Pharma R&D

Findacure UK Cure CHI

We continue the series of stories about the exciting collaboration between the UK charity Findacure and Elsevier. Findacure’s mission is to empower rare disease patient groups, facilitate treatment Continue reading “Building models for rare diseases” »

Did you just say Safety Governance Model?

Posted on May 27th, 2016 by

Pharmacovigilance

safety-first

We usually tend to think that our overall compliance to regulations and fulfilling our ethical commitment to patient safety is best answered through an established set of Policies and SOPs. We design processes around regulatory mandates and adjust to the complexity of the enterprise as much as we can, feeling confident that all our bases are covered. Continue reading “Did you just say Safety Governance Model?” »

Innovative Repurposing: New Drugs From Old

Posted on May 26th, 2016 by

Chemistry

health-846863_1280

Re-purposing of drugs is fraught with challenges, but can they be overcome so that patients benefit? The term re-purposing is often associated with the idea of saving a few bucks by taking something old and turning it into something useful (like transforming an empty wine bottle into a bird feeder). In the pharmaceutical world, though Continue reading “Innovative Repurposing: New Drugs From Old” »

Driving R&D Success: Deeper Science, Greater Collaboration

Posted on May 25th, 2016 by

Pharma R&D

As a senior strategic marketing professional at Elsevier, I often find myself telling our potential clients: to unlock your organization’s productivity, you need to strengthen your science—and we can help you do that. Continue reading “Driving R&D Success: Deeper Science, Greater Collaboration” »

Embracing and Releasing the Power of Data

Posted on May 24th, 2016 by

Pharma R&D

ball-63527_1280

Big data have huge potential in pharmaceutical research, especially now that the technology to manage, mine and assess the vast amount of available information is catching up with the reality of researchers’ needs. Where it once would have taken many months to effectively trawl Continue reading “Embracing and Releasing the Power of Data” »

  1. 1
  2. …
  3. 42
  4. 43
  5. 44
  6. 45
  7. 46
  8. …
  9. 55


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.